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uncommon in sporadic desmoid tumours
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Summary Desmoids are locally aggressive. non-metastasizing soft-tissue tumours. whose aetiology is still unclear. In patients affected with
familial adenomatous polyposis (FAP), the incidence of desmoids is much higher than in the general population. The APC gene. which is
responsible for FAP, is involved in the development of desmoids associated with this syndrome. In this study 16 sporadic and four FAP-related
desmoids were analysed in order to investigate the possible involvement of APC in non-syndromic cases also. The 5' end (exons 1-11) and
the coding portion of exon 15 of APC were screened using the in vitro synthesized-protein assay (IVSP). Exons 5, 6. 8-14, and a region of
exon 15 spanning codons 1036-1634 were investigated by single-strand conformation polymorphism (SSCP) analysis. APC germline
mutations were identified in all FAP patients, but not in sporadic cases. Somatic mutations were found in three FAP-associated desmoids
(750,o) and two sporadic tumours (12.5%). In one of the latter cases. both alleles were affected. These findings indicate a limited role of the
gene in the development of desmoid tumours outside FAP.
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Desmoid tumours. also knovwn as aggressive fibromatoses
(Mackenzie. 1972). are generallv considered to be soft-tissue
proliferations that do not metastasize. even if thev have a marked
tendency towards local invasion and a si1nificant risk of recur-
rence. The neoplastic nature of desmoids has recently been
assessed by molecular studies. which demonstrated that these
pathological entities are indeed clonal processes (Li et al. 1996:
Alman et al. 1997a: Lucas et al. 1997). Whereas desmoids are rare
in the general population. representing less than 0.1 % of all human
tumours. with an incidence of 2-4 cases per million per year (Pack
and Ehrlich. 1944: Reitamo et al. 1986). they occur with elevated
incidence (8-12%,-) in patients affected wmith familial adenomatous
polyposis (FAP) (Jones et al. 1986. Gurbuz et al. 1994). FAP is an
autosomal dominant genetic condition. characterized by the devel-
opment of hundreds to thousands of colorectal adenomas (polyps.)
which almost in ariablv lead to carcinomas. if prophylactic colec-
tomy is not performed (Bussey. 1975). This sxndrome may be
considered as a growth disorder affecting multiple body sites. being
characterized bx the occurrence. in addition to colorectal polyps. of
a varietx of extracolonic lesions. including thyroid and adrenocor-
tical tumours. epidermoid cysts. osteomas and desmoid tumours
(Campbell et al. 1994). The latter predominantly occur intra-
abdominaliv or in the abdominal wall. usually after surgerx (Jones
et al. 1986: Gurbuz et al. 1994). and represent an important cause of
morbiditv and mortality in FAP (Clark and Phillips. 1996).
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The gene responsible for FAP. termed APC for adenomatous
poliposis coli. maps to the long arm of chromosome 5 (q2l-22)
and was isolated in 1991 (Groden et al. 1991: Joslvn et al. 1991:
Kinzler et al. 1991: Nishisho et al. 1991 ).
In addition to Lermline mutations in individuals affected S ith
FAP. somatic inactivating mutations of the APC gene has-e been
identified in a high proportion of colorectal adenomas and carci-
nomas. both in FAP patients and sporadic cases (Mivoshi et al.
1992: Powell et al. 1992: Mivaki et al. 1994). This indicates that
the suppression of APC activity is a key step in early phases of
colorectal carcinogenesis. Although somatic mutations are
dispersed along the entire coding region of APC. more than 80%7-
ofthem are clustered between codons 1281 and 1554.
The complete inactivation of the APC gene. through the muta-
tion or the loss of the constitutionally wild-tx pe allele. was found
to be necessarv for the development of desmoid tumours that
occur in FAP patients (Mixvaki et al. 1993: Sen-Gupta et al. 1993:
Palmirotta et al. 1995). Also. in these tumours the somatic muta-
tions were found to cluster in a restricted region of APC (codons
1399-1584). The involvement of APC in non FAP-related
desmoids also is indirectly suggested bx the finding of deletions
affectingc chromosome Sq in a subgroup of these tumours (Bnrdce
et al. 1992. 1996). More recently. Alman et al (I1997b) reported the
identification ofAPC mutations in three of six sporadic aggressive
fibromatoses analvsed in exon 15.
In this stud. v-e screened the entire coding sequence ofAPC in
desmoid tumours from patients both with and without FAP in
order to investigate the occurrence in the two groups of a possible
common molecular mechanism.
-Present address: CRC Human Cancer Genetics Research Group. Addenbrooke's
Hospital. Hills Road. Carbndre CB2 2QQ. UK.
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Tabl 1 Clinical, patholgical and genetic characteristics of desmoid cases
Patient Age at Tunour APC Anamnestic data
no. sex diagnoss Tumour sit sizeb mato
FAP-related cases
2322
2428
2443
2444
Non FAP-relatedcases
2321
2323
2324
2325
2429
2430
2431
2432
2434
2435
2437
2438
2439
2440
2441
2442
M 20
24
27
28
M 15
F 51
Thorax wag
Intra-abdominal
Intra-abdominal recurrence*
Intra-abdominal recurrence
Abdominal wall
Intra-abdominal
M 30 Intra-abdominal
F 54
56
F 53
F 33
F 24
25
26
28
F 42
M 18
19
20
21
F 22
31
F 15
F 23
25
F 57
F 84
M 19
25
27
28
M 29
30
M 65
67
69
F 81
Right aximary region'
Recurrence
Thoraco-abdominal wall
Abdominal wall
Left shoulder; abdominal wall
Right thorax walr; right arm
Shoulder and abdominal recurrences
Thorax and abdominal recurrences
Intra-abdoninal
Right hand
Ax y region
A ary region recurrence*
Axilary region recurrence
Left thigh, posterior aspect
Recurrence'
Lef thigh, posterior aspect
Lef thorax wall
Recurrence'
Lumbosacral region
Buttock
Left axilary region
Recurrence
Recurrence
Recurrence*
Dorsal cervical region
Recurrence'
Left shoulder
Recurrence
Recurrence
Right dorsal lumbar region
M 53 Intra-abdominal
NA
7
10
18
G
11 G,S
11 G,S
7 G,S
9
7
5
19
16, 10
10; 12
4; 7
25; 25
17
NA
NA
5
9
7
3,5
23
NA
NI
S
S
NI
NI
NI
NI
NI
20 NI
2,5 NI
9 NI
NA -
NA -
8 -
12 NI
5 -
10 NI
5.5 -
5.5 -
9 NI
11 NI
12 NI
Total colectomy at 24
Restorative proctocoectomy at 12
Hysterectomy at 47;
restorative proctocokecomy at 51
Total coectomy at 28
Desmoid development during pregnancy
Congenital neuropsychic defict
Synchronous pancreatic cystoadenoma
Previous lcal trauma
Left breast excision for
fibroadenoma at 20;
multiple bilateral ovary cysts at 22
Surgical treatment for breast
carcinoma at 73
Rectum resection for
adenocarcinoma at 49;
two intestinal polyps
endoscopicaly resected at 51
aln cases where more than one tumour occurred, an asteriskindicates the surgical specimen that was analysed in the present study. bLength ofLarg axis (cn);
NA, data not available. cG, germline; S, somatic; NI, none identified.
MATERIALS AND METHODS
Patient samples
Twenty consecutive cases of desmoid turnours. surgically treated
between October 1992 and January 1995 at the Istituto Nazionale
Tumori ofMilan, were analysed in this study. Four were from FAP
patients and 16 were frompatients without clinical evidence ofFAP
by endoscopic examination, and with no cases ofFAP or desmoids
reported among relatives. Patients' sex, age at diagnosis, anatom-
ical site of tumours, tumour size and available anamnestic data are
reported in Table 1. The samples were frozen in liquid nitrogen
immediately after surgery and stored at -80C until use. When
possible, peripheral blood leucocytes (PBLs) were also obtained.
Molecular analysis
DNA and RNA purification and cDNA synthesis were performed
as previously described (Pensotti et al. 1997). Polymerase chain
reaction-single-strand conformation polymorphism (PCR-SSCP)
analysis was carried out using the primers and amplification
conditions reported by Groden et al (1991). PCR products were
heat denatured. loaded on 20% homogeneous Phast-gels
(Pharmacia Biotech). run on a Phast System1" apparatus under
non-denaturing conditions and visualized by silver staining. In
vitro synthesized-protein (IVSP) assay was performed as
described elsewhere (Powell et al. 1993). Four overlapping frag-
ments. spanning APC codons 686-1217 (S2). 1099-1693 (S3).
1555-2256 (S4) and 2131-2843 (S5). and covering the entire
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Figure 1 Strategy for APC mutation screening. Gene segments that were analysed by IVSP or by SSCP are indicated above and below the schematic
representatn of APC coxing region respecbvely. For each segment, the co-ordinates of first and last codons are indicated. The bcalization of the mutation
duster region (MCR) in colon tumours, and of the region inducing aH somatic mutations previsly identfied in FAP-related desmoids (FDMR: FAP-related
desmoid mutation region), are shown. The positos of the mutations idenified in the present study are indicated for comparson
coding portion of exon 15. were PCR amplified from genomic
DNA. An additional fragment spanning codons 2-515 (SIA) was
amplified from cDNA. Primer sequences and amplification condi-
tions are available upon request. PCR products showing altered
electrophoretic mobility by SSCP or IVSP were cloned into the
pCRI"'ll plasmid vector using the TA Cloning Kit (Invitrogen).
Individual recombinant clones were tested for the presence of
mutation in DNA inserts by SSCP or IVSP. Positive clones were
sequenced by the dideoxynucleotide chain termination method
with Sequenase and a'5S-dATP (Amersham). For sequencing. the
same primers used for PCR amplification were employed.
Loss ofheterozygosity (LOH) was investigated by PCR amplifi-
cation. from both tumour and PBL DNAs of the microsatellite
locus D5S346 as described (Spirio et al. 1991). PCR products were
examined using a Phast SystemT`' apparatus as described above.
RESULTS
The APC gene was investigated in the 20 desmoid tumours
included in the study by a combination of two methods (Figure 1).
IVSP was used to screen the entire coding portion of exon 15 and.
in 12 cases where RNA could be obtained and transcribed into
cDNA. a region at the 5' end ofthe gene including exons 1-11. In
addition. SSCP was used to screen exons 5. 6. 8-14 and a portion
ofexon 15 from segment 1SE to segment 151 (codons 1036-1634).
according to the subdivision established by Groden et al (1991).
The latter included the mutation cluster region (MCR) of
colorectal tumours and the region where all somatic mutations so
far reported in FAP-associated desmoids lie.
Mutations were detected in all four cases from FAP patients and
in two sporadic tumours (Table 2).
Desmoids from FAP patients canied gennline APC mutations, one
in exon 5 and three in exon 15. These were identifiedduring a system-
atic investigation of a large panel of individuals affected with the
syndrome (data unpublished). In addition to these mutations. three
FAP-related desmoids were found to cany somatic APC mutations.
i.e. mutations not present in the corresponding PBL DNA. One muta-
tion consisted in a 5-bp deletion affecting codons 1309-1311. which
represents the germline mutation most frequently detected in FAP
individuals (Miyaki et al. 1995). The odter two were frameshifts: a
l-bpdeletion and 1-bpinsertion at codons 1534and 1558respectively.
In tumour 2323. a sporadic case, a nonsense mutation at codon
1450 was identified. This mutation was not present in the constitu-
tional DNA.
Two mutations were identified in sporadic desmoid 2324. One
consisted in the deletion of23 bp from codon 1142 to codon 1149.
The other was a nonsense mutation affecting codon 1469. Analysis
of PBL DNA of the patient revealed that both mutations were
somatic. In order to verify whether the two mutations lay on the
same or on different alleles, a region spanning codons 1099-1693.
corresponding to 1VSP segment S3. was amplified by PCR from
tumour DNA and cloned into plasmid vectors. Sequence analyses
revealed that the mutations segregated into different recombinant
clones (Figure 2). This demonstrated that the identified mutations
affected different alleles in desmoid 2324 DNA.
PBL DNAs of eight individuals (the four FAP patients and
sporadic cases no. 2324. 2325. 2431 and 2442) were available for
LOH analysis. All subjects were informative. i.e. constitutional
heterozygous. at the D5S346 locus. closely linked to the APC
gene (Spirio et al. 1991). In all cases both germline alleles were
found to be maintained in the corresponding tumour DNAs. Two
intragenic polymorphisms. one in exon 11 (Groden et al. 1991).
and one in exon 13 (Fodde et al. 1992) were also analysed by
SSCP. Two patients. one with FAP (no. 2444) and one sporadic
(no. 2324). were informative for both polymorphisms and main-
tained heterozygosity in tumour DNA. whereas the other six
cases were constitutionally homozygous for both polymorphisms
(data not shown).
DISCUSSION
The screening of the APC gene in FAP- and non-FAP-related
desmoid tumours revealed substantial differences between the two
groups. Germline APC mutations were identified in all four FAP
patients. In contrast. no constitutional abnormalities of the gene
were found in sporadic desmoids. It has been reported recently that
germline APC mutations are responsible for an inheritable form of
susceptibility to desmoids. which may occur in individuals that do
not carry the high number of colonic polyps (>100) characteristic
ofFAP (Eccles et al. 1996: Scott et al. 1996). However. our results
suggest that the majority ofdesmoid tumours that arise in patients
without evidence of FAP are not due to constitutional defects in
the APC gene.
At the somatic level. APC mutations were found in desmoids
both from FAP patients and sporadic cases. but at significantly
different frequencies. Three of the four FAP-associated desmoids
(75%) carried somatic mutations predicted to lead to the truncation
of APC protein products. Although not formally demonstrated. it
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Table 2 Mutations of the APC gene in desmoid tumours
Case Mutation Codons Nucleotide Consequewce of mutation
no. typ attecte& change
FAP-related cases
2322 G 1538 del(GA) Frameshift to stop at codon 1542
2428 G 935 TAC-*TAA Stop at same codon
S 1558 ins(A) Frameshift to stop at codon 1559
2443 G 213 CGA-*TGA Stop at same codon
S 1534 del(G) Frameshift to stop at codon 1564
2444 G 1464-1465 del(AGAG) Frameshift to stop at codon 1471
S 1309-11 del(AAAGA) Frameshiftto stop atcodon 1312
Non FAP-related cases
2323 S 1450 CGA-*TGA Stop at same codon
2324 S 1142-1149 del 23 bp Frameshift to stop at codon 1146
S 1469 CAA-*TAA Stop at same codon
a G. germline: S. somatic.
- cDNA sequence Gen Bank accession no. M74088.
A B
T C G A
C
T C G A
3423
3447
3- 3-
A--
Figure 2 Sequence analysis of two independent plasmid dones containing an APCfragment (codons 1099-1693) dernved by PCR amplification of tumour
2324 DNA. (A) Detection of a 23-bp deletion in clone p2324.6. The dotted line indicates the position of the deletion. The numbers represent the co-ordinates in
the cDNA sequence of APC of nucleotides flanking the deleted region. assuming as 1 the adenosine of the translation start codon. (B) Detection in clone
p2324.3 of a C to T transition creating a stop signal (TAA) at codon 1469. (C) Maintenance of the wild-type sequence at codon 1469 in plasmid p2324.6
is likely that these mutations affected the constitutionally w-ild-
type alleles. thus leading to the complete inactivation ofAPC. as
documented in previous studies (Mivaki et al. 1993: Sen-Gupta et
al. 1993: Palmirotta et al. 1995). On the other hand. truncating
APC mutations were observed in onlv 2 of the 16 sporadic cases
(12.5%). a proportion significantly lower than in FAP patients
(P = 0.03. Fisher's exact test). and only in one of these did we
detect the inactivation ofboth alleles.
The fraction of mutated sporadic desmoids observed in this
study was lower than that reported by Alman et al (1997b). who
identified APC mutations in three of six cases (50%). However.
this difference was not significant (P =0.10. Fisher's exact test).
and might be caused by a sampling bias.
It seems unlikely that the low rate ofAPC mutations detected in
sporadic cases. in comparison with FAP-related ones. is attribut-
able to a reduced sensitivity of the screening protocol employed.
as both groups were analysed using the same approach. However.
it cannot be excluded. at least in theory. that sporadic desmoids
carrv APC mutations that tie preferentially in those regions of the
gene that were not analvsed in this study. including regulatory
sequences. It is also possible that in sporadic desmoids the APC
gene is affected by mutations that are not detectable bv the tech-
niques that were used. For example. missense mutations in exonic
regions that xWere analysed only by IVSPxould has-e been missed.
as this method only detects nonsense and frameshift mutations.
These possibilities. however. would be in contrast with previous
observations. which suggest that the development of desmoids
mediated by the APC gene requires the presence of at least one
allele carrying a truncating mutation near or bevond codon 1444
(Palmirotta et al. 1995). In fact. our results are in keeping with this
hypothesis. as in all cases. both FAP and sporadic. in which APC
alterations were identified. at least one allele was mutated. either
at aermline or somatic level. in a region spanning codons
1450-1558.
Total or partial APC gene deletion. a possibility sugrgested by
cytogenetic observations (Bridge et al. 1992. 1996). should also be
considered. Unfortunately. this could not be adequately examined
in this studv. as the search for allele losses affecting APC could be
performed only in four of the sporadic tumours. All were found to
be heterozygous for the flankingc markers D5S346. but only one
case. no. 2324 with somatic mutations in both APC alleles. was
informative for the two intragenic polymorphisms investigated.
Even considering the above-mentioned technical limitations.
our data suggest that mutations in the APC gene contribute to the
development of only a small fraction of sporadic desmoids. The
protein encoded by APC takes part in co-ordinated pathwayrs that
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control cell to cell adhesion and cell rmigration (Nathke et al. 1996:
Barth et al. 1997). These functions are mediated through binding
to different cellular proteins. one of which. the 5-catenin. appears
to be down-regulated by APC itself (Munemitsu et al. 1995). It is
conceivable that disturbances in these cellular pathways may
promote the uncontrolled growth of mesenchymal cells. which
aives rise to desmoid formation. In principle. different genetic
mechanisms may be responsible for these disturbances. In FAP
patients the inactivation of both APC alleles is selected for.
because of the presence of germline mutations of the gene. In
sporadic cases. other genetic alterations may occur with similar
probabilities to APC mutations. These alterations might affect
genes whose products interact directly or indirectly with the APC
protein. Among these. an obvious candidate is the S-catenin gene
(CT2VNB1). which was recently reported to be mutated in colon
cancer and in melanoma cell lines (Mlorin et al. 1997: Rubinfeld et
al. 1997). However. genes mapped to chromosomes 8 and 20. that
have been found to be frequently trisomic in sporadic desmoids
(Fletcher et al. 1995: Mertens et al. 1995: Qi et al. 1996). should
also be considered.
The identification of inactivating APC mutations in desmoids.
although limited to a small proportion of cases in sporadic
tumours. might have important consequences for the treatment of
these neoplasias. At present. the chemotherapy of desmoids is
mainly based on the use of non-steroidal anti-inflammatorv druus
(NSAIDs) (Clark and Phillips. 1996). Among these. one of the
most commonly employed is sulindac. Recently. sulindac was
shown to increase the expression of APC mRNA in vitro
(Schnitzler et al. 1996). and it has been suggested that this effect
might explain, at least in part. the growth inhibition properties of
the drug. If this were true. one should expect that sulindac has no
or little effect in inducing the regression of desmoids that do not
express wild-type APC protein. However, no data are at present
available to confirm this hypothesis.
Finally, it must be noted that the tmo sporadic desmoids in
which mutations ofAPC were detected were also the only two non
FAP-related tumours that occurred in the abdominal wall.
Interestinglv. 10 out of the 15 FAP-associated desmoids that have
been reported to carry somatic APC mutations were also localized
in the abdominal wall (Mivaki et al. 1993: Sen-Gupta et al. 1993:
Palmiirotta et al. 1995 and present study). This might suggest that
the presence of somatic APC mutations in desmoid DNA. rather
than being dependent on the germline status of the patients.
reflects the anatomical site of tumour appearance. However.
somatic mutations of APC were also reported in FAP-related
desmoids that originated intra-abdominally (Mivak-i et al. 1993
and present study), which is by far the most frequent site ofoccur-
rence ofdesmoids in FAP patients (Jones et al. 1986: Gurbuz et al.
1994). but not in the two intra-abdominal sporadic cases (no. 2429
and 2442) analysed in this study.
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